ArticleCancer cell international2023

The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway.

Liyun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.